W celu świadczenia usług na najwyższym poziomie stosujemy pliki cookies. Korzystanie z naszej witryny oznacza, że będą one zamieszczane w Państwa urządzeniu. W każdym momencie można dokonać zmiany ustawień Państwa przeglądarki. Zobacz politykę Cookies

News

22 December, 2025
Recommendation of the President #HPP #48aa – Prevention and early detection of head and neck cancers
read more
22 December, 2025
Recommendation of the President – Rezurock (belumosudil)
read more
22 December, 2025
Communication of the meeting of Transparency Council No. 52/2025 on 8 December 2025 with resolutions
read more
17 December, 2025
CAPRICORD – invitation to patient organizations to cooperate
read more
17 December, 2025
The Tariff Council meeting 1/2026 on 29 January 2026
read more
17 December, 2025
The Tariff Council meeting 15/2025 on 19 December 2025
read more
17 December, 2025
The Transparency Council meeting 54/2025 on 22 December 2025
read more
15 December, 2025
AOTMiT – we build capacity in the field of biosimilars
read more
12 December, 2025
Communication of the meeting of Tariff Council on 3 December 2025
read more
11 December, 2025
Guaranteed benefits covering the implementation of nutritional standards in healthcare facilities for all healthcare services provided as part of hospital treatment
read more
10 December, 2025
86. Ongoing cooperation – obtaining medical and cost data from hospital treatment for 2024 (WB24)
read more
08 December, 2025
The Transparency Council meeting 53/2025 on 15 December 2025
read more
08 December, 2025
Communication of the meeting of Transparency Council No. 51/2025 on 1 December 2025 with resolutions
read more
08 December, 2025
Communication of the meeting of Transparency Council No. 51/2025 on 1 December 2025 with resolutions
read more
05 December, 2025
Publication AWA
read more
05 December, 2025
Status of work in December
read more
04 December, 2025
Recommendation of the President – Yervoy (ipilimumab)
read more
04 December, 2025
Recommendation of the President – Opdivo (nivolumab)
read more
04 December, 2025
Recommendation of the President – Kayfanda (odevixibat)
read more
28 November, 2025
Tariff Council meeting 14/2025 on 3 December 2025
read more
28 November, 2025
Publication AWA
read more
28 November, 2025
Status of work in December
read more
28 November, 2025
Recommendation of the President #HPP #48aa – Prevention of lymphedema after breast cancer treatment
read more
28 November, 2025
Opinion of the President – Program for the early detection of visual impairments in 5-year-old children residing in Bielsko-Biała for the years 2026-2028
read more

Home page

News Publications Publikacje BIP

#webinar agenda Aktualności announcement of the President azathioprinum Bimzelx Collegium AOTMiT colorectal cancer communication Communication from the Transparency Council Communication on the Tariff Council Cost Accounting Standard Council for Tariffs Affairs covering neonatal care cyclophosphamidum Data acquisition dental treatment services diseases of the organ of vision drug programme Empliciti entecavirum etanercept Fycompa gastroscopy glaucoma health policy program health policy programme health policy programme on breast cancer health policy programme on infertility treatment Health Policy Programmes Impavido in vitro Inovelon Jardiance Meeting of the Transparency Council methotrexatum Milupa Basic-P minimum wage increases mycophenolate mofetil new new tariffs news Notice Notice of the President Ontozry Onureg Opdivo Opdivo (nivolumab)opinion Opinion of the President Opinion of the Transparency Council Ospolot Ozurdex perinatal care Ponvory Position of the Transparency Council Press conference Recommendation Recommendation of the President Renastep report Rezurock sirolimus Suliqua Tariff Council Tariffs Council Tarification Plan 2025 tenofovirum disoproxilum the drug programme B.44 the drug programme B.82 The Meeting of the Tariffs Council trainings Transparency Council Tremfya update Vivitrol Yervoy

Pokaż więcej ↓

Pokaż mniej ↑

Telefon

Page header

News

Recommendation of the President #HPP #48aa – Prevention and early detection of head and neck cancers

Recommendation of the President – Rezurock (belumosudil)

Communication of the meeting of Transparency Council No. 52/2025 on 8 December 2025 with resolutions

CAPRICORD – invitation to patient organizations to cooperate

The Tariff Council meeting 1/2026 on 29 January 2026

The Tariff Council meeting 15/2025 on 19 December 2025

The Transparency Council meeting 54/2025 on 22 December 2025

AOTMiT – we build capacity in the field of biosimilars

Communication of the meeting of Tariff Council on 3 December 2025

Guaranteed benefits covering the implementation of nutritional standards in healthcare facilities for all healthcare services provided as part of hospital treatment

86. Ongoing cooperation – obtaining medical and cost data from hospital treatment for 2024 (WB24)

The Transparency Council meeting 53/2025 on 15 December 2025

Communication of the meeting of Transparency Council No. 51/2025 on 1 December 2025 with resolutions

Communication of the meeting of Transparency Council No. 51/2025 on 1 December 2025 with resolutions

Publication AWA

Status of work in December

Recommendation of the President – Yervoy (ipilimumab)

Recommendation of the President – Opdivo (nivolumab)

Recommendation of the President – Kayfanda (odevixibat)

Tariff Council meeting 14/2025 on 3 December 2025

Publication AWA

Status of work in December

Recommendation of the President #HPP #48aa – Prevention of lymphedema after breast cancer treatment

Opinion of the President – Program for the early detection of visual impairments in 5-year-old children residing in Bielsko-Biała for the years 2026-2028